International Immunology, Vol. 14, No. 7, pp. 801-812,
July 2002
© 2002 Japanese Society for Immunology
Staphylococcal enterotoxin B-induced activation and concomitant resistance to cell death in CD28-deficient HLA-DQ8 transgenic mice
1 Department of Immunology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
Correspondence to: C. S. David; E-mail: davic4{at}mayo.edu
Transmitting editor: G. J. Hämmerling
HLA class II molecules present superantigens more efficiently than their murine counterpart. Therefore, transgenic mice expressing HLA-DQ8 with and without CD28 were used to address the role of CD28 in staphylococcal enterotoxin B (SEB)-driven immune responses. SEB-induced in vitro proliferation of naive DQ8.CD28/ splenocytes was comparable to DQ8.CD28+/+ cells, and was several fold higher than that of C57BL/10 and BALB/c splenocytes. SEB-activated, naive DQ8.CD28/ cells in vitro produced significantly less IL-2, IL-4 and IL-10 than DQ8.CD28+/+ cells, while IFN-
and IL-6 production was comparable. SEB-induced in vivo expansion of CD4+ T cells and, to a greater extent, CD8+ T cells was compromised in DQ8.CD28/ mice, indicating that SEB-induced proliferation of CD8+ T cells is more dependent on CD28 co-stimulation. Upon re-stimulation, SEB-primed CD28+/+ T cells failed to proliferate but were capable of producing cytokines. Conversely, CD28/ T cells were capable of proliferation, but not cytokine production. SEB-primed CD28-deficient cells produced significantly less nitric oxide when compared to CD28-sufficient cells following re-stimulation with SEB. CD28+/+ and not CD28/ mice were highly susceptible to SEB-induced lethal shock characterized by significantly elevated serum IFN-
. Thus, (i) efficient presentation of SEB by HLA-DQ8 circumvents co-stimulation through CD28, (ii) unique CD28-derived signals are mandatory for generation of certain effector functions, and (iii) absence of CD28-derived signals confers resistance to activation-induced cell death and protects mice from SEB-induced shock.
Keywords: co-stimulatory molecule, MHC, rodent, superantigen, transgenic/knockout
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Rajagopalan, M. K. Smart, R. Patel, and C. S. David Acute Systemic Immune Activation following Conjunctival Exposure to Staphylococcal Enterotoxin B. Infect. Immun., October 1, 2006; 74(10): 6016 - 6019. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rajagopalan, K. Iijima, M. Singh, H. Kita, R. Patel, and C. S. David Intranasal Exposure to Bacterial Superantigens Induces Airway Inflammation in HLA Class II Transgenic Mice Infect. Immun., February 1, 2006; 74(2): 1284 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Faulkner, A. Cooper, C. Fantino, D. M. Altmann, and S. Sriskandan The Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm J. Immunol., November 15, 2005; 175(10): 6870 - 6877. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rajagopalan, M. M. Sen, and C. S. David In Vitro and In Vivo Evaluation of Staphylococcal Superantigen Peptide Antagonists Infect. Immun., November 1, 2004; 72(11): 6733 - 6737. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rajagopalan, Y. C. Kudva, L. Chen, L. Wen, and C. S. David Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the {beta} cells of islets of Langerhans Int. Immunol., September 1, 2003; 15(9): 1035 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rajagopalan, M. K. Smart, C. J. Krco, and C. S. David Expression and Function of Transgenic HLA-DQ Molecules and Lymphocyte Development in Mice Lacking Invariant Chain J. Immunol., August 15, 2002; 169(4): 1774 - 1783. [Abstract] [Full Text] [PDF] |
||||


